Home ⇢ Genome Valley Components ⇢ Upcoming Projects


Genome Valley has witnessed an increase in investments of various leading global companies. With the availability of excellent support infrastructure and dynamics of the cluster, life science companies and lab space developers among others have committed/started development of their facilities in the cluster.

  • MN is currently developing building 4500 in MN Synergy Square 2. The project is an approximately 250,000 SF state-of-the-art multi-tenanted laboratory space, providing a campus-like environment for life sciences companies.
  • ATGC, AgriGenome, Genesys, Ferring and Chemo are setting up facilities in Genome Valley for their R&D. Biological E is setting up its new pharma division as well as a new facility on its SEZ land.
  • Apart from these companies, there are several other research and manufacturing facilitates yet to be developed in Genome Valley Phase 3 (Karkapatla) and the state government is actively promoting the cluster.
  • Alembic Pharmaceutical, an integrated research facility, has plans for multifold expansion in MN Park in the coming years. Other upcoming projects of MN include building 3600, spread across approximately 200,000 SF in MN Synergy Square 3, being developed for grade A research spaces.

News & Events

Quick Links